Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in Children

This study has been completed.
Sponsor:
Collaborators:
Mbarara University of Science and Technology
Massachusetts General Hospital
Harvard Medical School
Medecins Sans Frontieres, Netherlands
Information provided by (Responsible Party):
Epicentre
ClinicalTrials.gov Identifier:
NCT01388842
First received: November 23, 2010
Last updated: February 29, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2014
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)